Cathy Ann-Rasmussen Ivarie

Title: Innovations by Cathy Ann-Rasmussen Ivarie

Introduction

Cathy Ann-Rasmussen Ivarie is a notable inventor based in Marshall, Wisconsin. She has made significant contributions to the field of biomedical engineering, particularly in the development of skin substitutes. With a total of two patents to her name, her work focuses on improving wound healing through innovative skin technologies.

Latest Patents

Cathy's latest patents include "Skin substitutes with improved purity," which relates to in vitro cultured skin substitutes. This invention emphasizes the use of NIKS cells in developing cultured skin substitutes. Another significant patent is "Human skin equivalents expressing exogenous polypeptides," which provides engineered human skin equivalents designed to express exogenous proteinase inhibitor polypeptides, such as TIMP-1. This invention also outlines methods for treating wounds using these engineered skin equivalents.

Career Highlights

Cathy Ann-Rasmussen Ivarie is associated with Stratatech Corporation, where she continues to advance her research and innovations. Her work has been pivotal in enhancing the effectiveness of skin substitutes, which are crucial for wound healing and tissue regeneration.

Collaborations

Some of her notable coworkers include B Lynn Allen-Hoffmann and John M Centanni, who have collaborated with her on various projects related to skin substitutes and wound healing technologies.

Conclusion

Cathy Ann-Rasmussen Ivarie's contributions to the field of biomedical engineering through her patents and work at Stratatech Corporation highlight her commitment to advancing medical technology. Her innovations in skin substitutes are paving the way for improved treatments in wound care.